Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envista Holdings (NVST) Other financing activities (2019 - 2026)

Envista Holdings' quarterly Other financing activities came in at -$400000.0 in Q2 2026, down 100.0% quarter-over-quarter from -$200000.0 in Q2 2024.

Envista Holdings has reported Other financing activities for 6 years, with the latest figure at -$400000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Other financing activities changed N/A year-over-year to -$400000.0; the trailing twelve-month figure through Apr 2026 stood at -$400000.0 (down 100.0% YoY), and the FY2024 full-year result was -$800000.0, down 900.0% from the prior year.
  • Other financing activities for Q2 2026 stood at -$400000.0, down from -$200000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.6 million in Q2 2023, with the low at -$1.4 million in Q3 2023.
  • Average Other financing activities over 3 years is -$183333.3, with a median of -$300000.0 recorded in 2024.
  • Peak annual rise in Other financing activities reached 112.5% in 2024, while the deepest fall reached 112.5% in 2024.
  • Tracing NVST's Other financing activities over 3 years: stood at -$100000.0 in 2023, then sank by 100.0% to -$200000.0 in 2024, then sank by 100.0% to -$400000.0 in 2026.
  • The last three Other financing activities figures came in at -$400000.0 (Q2 2026), -$200000.0 (Q2 2024), and -$600000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Envista Holdings 3.87 Bn 2.79 Bn 390.10 Mn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -400,000.00
Apr 3, 2026 -400,000.00
Jun 28, 2024 -200,000.00
Jun 28, 2024 -200,000.00
Mar 29, 2024 -600,000.00
Mar 29, 2024 -600,000.00
Dec 31, 2023 -100,000.00
Dec 31, 2023 -100,000.00
Sep 29, 2023 -1.40 Mn
Sep 29, 2023 -1.40 Mn
Jun 30, 2023 1.60 Mn
Jun 30, 2023 1.60 Mn
Dec 31, 2021 -600,000.00
Dec 31, 2021 -600,000.00
Oct 1, 2021 -5.60 Mn
Oct 1, 2021 -5.60 Mn
Jul 2, 2021 5.90 Mn
Jul 2, 2021 5.90 Mn
Apr 2, 2021 400,000.00
Apr 2, 2021 400,000.00
Dec 31, 2020 -12.90 Mn
Dec 31, 2020 -12.90 Mn
Oct 2, 2020 18.30 Mn
Oct 2, 2020 18.30 Mn
Jul 3, 2020 -6.60 Mn
Jul 3, 2020 -6.60 Mn
Apr 3, 2020 5.50 Mn
Apr 3, 2020 5.50 Mn
Dec 31, 2019 2.40 Mn
Dec 31, 2019 2.40 Mn